83/100 A · Moderate risk
No major risk flags in public sources TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.
  • ℹ️ Foreign-controlled

BAYER AS

Active Aksjeselskap 📍 Oslo Wholesale trade Active for 61 years

Aksjeselskap · RC 911268647 · Active since 1964

A

Overview

BAYER AS is an aksjeselskap registered in Oslo, Norway, since 1964. The company operates in the wholesale trade sector. Its TraceComp score of 83 (A) indicates solid fundamentals and low apparent risk. With 61 years of operations, the company has an established track record in its market.

Company Information

Registration Number
911268647
Legal Form
Aksjeselskap
Registered
1964-09-30
Address
Oslo

Financial Profile

Latest filed accounts: FY 2024

Revenue (2024) —
Net Income 23,940,000 EUR
Total Assets 96,115,000 EUR
Altman Z 1.66 grey

Multi-year financials & ratios

1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Officers & Management

10 officers/directors on file — names, roles, appointment & resignation dates.

NameRoleStatus
Erik Helstad Daglig leder Current
+ 9 more in the full report

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Research Output

Active research organization. 177 publications · 11,827 citations · h-index 55 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Medicine (100%).

See full research profile — top researchers & publications →

Source: OpenAlex (CC0). Objective publication & citation counts.

Patent Portfolio

Active patent holder. 8 patents · 8 active · 8 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Corporate Group & Ownership

Parent entities from the GLEIF global ownership graph (LEI Level 2).

RelationshipParent entityCountry
Direct parent Bayer Aktiengesellschaft DE
Ultimate parent Bayer Aktiengesellschaft DE

Risk Signals

No adverse legal events have been recorded for this company.

  • Profitable: positive net income in FY 2024

Data Sources & Freshness

Data sourced from: bulk register.